PharmaCielo’s Anthony Wile: How the executive is bringing new respectability to cannabis
Get to know more about PharmaCielo’s Anthony Wile, a Canadian entrepreneur who has his eyes set on capitalizing on the cannabis market in Colombia.
The infamous Colombian “drug lord” of the past has been replaced by the savvy and respected businessman of the future.
Anthony Wile is the Canadian born and bred entrepreneur, business strategist, author and global market investor who also is the prescient chief executive of Toronto-based PharmaCielo Ltd. Five years ago, at the same time as he completed his book, “Financial Freedom,” he determined that legalized cannabis was on the cusp of explosive global growth. From that recognition, he took the lead in reshaping Colombia’s position in the marketplace.
Having done substantial business in Colombia, Anthony Wile recognized that the Latin American nation was in an ideal position to capitalize on the cannabis market, given a climate that, in every respect, was ideal. In addition to the ideal, year-round growing conditions in this equatorial country, a forward-thinking new government was in place to set the right direction from a regulatory, economic and business perspective.
Colombia’s legalization of medical cannabis for domestic use and import puts it in a strong position to grow into owning a fifth of a potential $40 billion global market.
Wile backed his confidence in Colombia’s future role with advocacy, starting with flower growers. Colombia is the leading flower-producing nation, and growers already had an infrastructure in place, Wile believed, to support the nascent industry. The cost structure of growing in this region would be 5-cents per gram versus the $1.50 when grown in northern greenhouses.
He put his money where his mouth was, too, partnering with a long-time leader of the Colombian flower industry to launch PharmaCielo. PharmaCielo, or “medicine from the heavens”, would set the standards for quality product and business practices.
Then, he began advocating with investors on the company’s opportunity to be a leading producer of quality medical cannabis. PharmaCielo has raised approximately $100 million among investors to advance growth in Colombia as it readies to go public on the Toronto Stock Exchange.
“The way I see it,” Anthony Wile says, “a Canadian-Colombian venture would be a winning combination in order to win a significant share of this growing business. Canada has been an innovative leader in developing a carefully regulated medical cannabis industry. And Colombia has the idea conditions in climate, economy and people for growing according to our shared high standards.”
In late 2017, Colombia’s legislation and regulations legalizing medicinal cannabis became effective. PharmaCielo became the first company to be licensed to grow and process the plant, and holds the largest amount of acreage, outside the city of Medellin that once was the base of notorious drug lord Pablo Escobar. A second site in Colombia’s Cauca region hosts a joint venture whose proceeds are earmarked for the local community.
“We share with the government the understanding that thriving local economies are essential as the backbone to a healthy national economy,” Wile explains. “Our Cauca operation is the first of many we have planned to help boost communities that were hurt most by the civil unrest of the past.”
Anthony Wile’s role advancing the business and economic prospects of Colombia and its people have not gone unrecognized. In August, the Nova Scotia native who is fluent in Spanish and English, became a citizen of Colombia. The honor, conferred by special presidential decree, recognizes his contributions to bringing Canada and Colombia together, now with dual citizenship in both.
Ephion Health Raises €300,000 and Plans the Launch to Germany, France, and the UK
To date, Ephion has agreements with five hospitals for the implementation of its Ephion Mobility technology in neuromuscular diseases: the...
The First Application to Grow Medical Cannabis Was Received in Poland
Cultivation of cannabis for medical purposes is possible only under certain controlled conditions - in research institutes under the supervision...
This Was One of the Narrowest Based Stock Market Rallies We’ve Ever Seen
The stock market rallied this week but many lag. Gold was up then tanked following the jobs report. Oil rebounded...
A Look at Barron’s Bond Yields – 1934 to 2023
This inflation hurt the bondholders for both IG and BG bonds, those who lent dollars worth more, much more than...
Why Is Everyone So Afraid of ChatGPT?
ChatGPT is clearly the most popular AI tool today, not least in the marketing industry, and copywriting is a sector...
Featured1 week ago
Debt Ceiling Wars Again: Will the US Fall into Recession
Biotech2 weeks ago
Mikrobiomik Seeks Up to €3 Million in One Financing Round
Crypto5 days ago
Dogecoin: Doge Whales Return Due to Bullish Metrics
Featured2 weeks ago
QED Investors Closes Two Funds for Nearly $1 Billion to Invest in Fintech Companies
You must be logged in to post a comment Login